scholarly journals Direct medical costs of neonatal respiratory distress syndrome in two specialized public hospitals in Mexico

2014 ◽  
Vol 56 (6) ◽  
pp. 612 ◽  
Author(s):  
Silvia Martínez-Valverde ◽  
Angélica Castro-Ríos ◽  
Guillermo Salinas-Escudero ◽  
Miguel A Villasis-Keever ◽  
Juan Garduño-Espinosa ◽  
...  
Keyword(s):  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Resource Use ◽  
Distress Syndrome ◽  
Medical Costs ◽  
Public Hospitals ◽  
Direct Medical Costs ◽  
Clinical Complications ◽  
Care Payer ◽  
Clinical Records

Objective. To estimate direct medical costs (DMC) associated with treatment of Respiratory Distress Syndrome (RDS) in newborns (NB) in two specialized public hospitals in Mexico. Materials and methods. The perspective used was health care payer. We estimated DMC associated with RDS management. The pattern of resource use was established by reviewing clinical records. Microcosting and bootstrap techniques were used to obtain the DMC. Estimated costs were reported in 2011 US dollars. Results. Average DMC per RDS event was 14226 USD. The most significant items that account for this cost were hospitalization (38%), laboratory and diagnostic exams (18%), incubator time (10%), surfactant therapy (7%), and mechanical ventilation (7%). Conclusion. Average DMC in NB with RDS fluctuated in relation to gestational age weight at birth and clinical complications presented by patients during their hospitalization.

scholarly journals COST-EFFECTIVENESS ANALYSIS ON THE USE OF PARENTERAL NUTRITION WITH D10-CA GLUCONATE AND D5 1/4NS IN NORMAL-WEIGHT NEONATES WITH RESPIRATORY DISTRESS SYNDROME

2017 ◽  
Vol 9 ◽  
pp. 63
Author(s):  
Fitria Ningsih ◽  
Rani Sauriasari ◽  
Agusdini Banun Saptaningsih
Keyword(s):  
Cost Effectiveness ◽  
Parenteral Nutrition ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Distress Syndrome ◽  
Medical Costs ◽  
Pulse Frequency ◽  
Normal Weight ◽  
Average Weight ◽  
Direct Medical Costs

Objectives: This retrospective cohort study aimed to compare the cost-effectiveness of using D10-CaGluconate and D5 1/4NS preparations in normalweightneonatal patients with Respiratory Distress Syndrome (RDS) in Kambang General Hospital, Jambi, Indonesia.Methods: The research was conducted from September 2014 to June 2015. The study participants were divided into two groups; D10-CaGluconatewas administered to 40 patients and D5 1/4NS to 43 patients. Effectiveness was assessed based on the changes in the physical examination results,average weight gain (28.48 and 23.49 g/day), blood glucose levels (26.73 and 26.42 mg/dL), respiratory rate (−12.35 breaths/minute and −7.77breaths/minute), pulse frequency (−10.98 and −8.07 ±), and body temperature (0.013°C and 0.012°C) of the patients in the D10-CaGluconate andD5 1/4NS groups, respectively.Results: The average direct medical costs of using D10-CaGluconate and D5 1/4NS were 458,290 IDR and 408,347 IDR, respectively. The average costeffectivenessratio value of total direct medical costs for D10-CaGluconate preparation was 35,207,467 IDR while that for D5 1/4NS was 33,958,602IDR. The direct medical cost of the incremental cost-effectiveness ratio mean value of the D5 1/4NS preparation that compared to the D10-CaGluconatepreparation was 10,017,210 IDR.Conclusions: The parenteral nutrition preparation of D10-CaGluconate is more cost-effective than that of D5 1/4NS.

Acute respiratory distress syndrome: Resource use and outcomes in 1985 and 1995, trends in mortality and comorbidities

2000 ◽  
Vol 15 (3) ◽  
pp. 91-96 ◽  
Author(s):  
Maria Dolores Pola ◽  
Pedro Navarrete-Navarro ◽  
Ricardo Rivera ◽  
Enrique Fernández-Mondejar ◽  
Benjamin Hurtado ◽  
...  
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Resource Use ◽  
Distress Syndrome

scholarly journals Healthcare Resource Use and Costs in Long-Term Survivors of Acute Respiratory Distress Syndrome

2017 ◽  
Vol 45 (2) ◽  
pp. 196-204 ◽  
Author(s):  
A. Parker Ruhl ◽  
Minxuan Huang ◽  
Elizabeth Colantuoni ◽  
Robert K. Lord ◽  
Victor D. Dinglas ◽  
...  
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Resource Use ◽  
Distress Syndrome ◽  
Healthcare Resource ◽  
Healthcare Resource Use ◽  
Long Term Survivors

French hospitals faced with the COVID-19 pandemic: the reality of logistical strategies

2020 ◽  
Vol 26 (6) ◽  
pp. 1-5
Author(s):  
Gilles Paché
Keyword(s):  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Health Systems ◽  
Sharp Increase ◽  
Distress Syndrome ◽  
Public Hospitals ◽  
Private Companies ◽  
Number Of Patients

The COVID-19 pandemic has challenged many health systems, particularly in France, Italy and Spain. The very sharp increase in the number of patients with acute respiratory distress syndrome led public hospitals to implement management-inspired logistical strategies. This comment focuses on the French system and underlines that hospitals tend to be increasingly managed like private companies.

scholarly journals High Burden of Acquired Morbidity in Survivors of Pediatric Acute Respiratory Distress Syndrome

2021 ◽  
Author(s):  
Sin Wee Loh ◽  
Ming Ying Gan ◽  
Judith Ju-Ming Wong ◽  
Chengsi Ong ◽  
Yee Hui Mok ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Respiratory Distress Syndrome ◽  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Hospital Discharge ◽  
Functional Outcomes ◽  
Distress Syndrome ◽  
Severity Of Illness ◽  
Bivariate Analysis ◽  
Clinical Records

Introduction: With improving mortality rates in pediatric acute respiratory distress syndrome (PARDS), functional outcomes in survivors are increasingly important. We aim to describe the change in functional status score (FSS) from baseline to discharge and to identify risk factors associated with poor functional outcomes. Methods: We examined clinical records of patients with PARDS admitted to our pediatric intensive care unit (PICU) from 2009 to 2016. Our primary outcome was acquired morbidity at PICU and hospital discharge (defined by an increase in FSS ≥3 points above baseline). We included severity of illness scores and severity of PARDS in our bivariate analysis for risk factors for acquired morbidity. Results: There were 181 patients with PARDS, of which 90 (49.7%) survived. Median pediatric index of mortality 2 score was 4.05 (1.22, 8.70) and 21 (26.6%) patients had severe PARDS. 59 (65.6%) and 14 (15.6%) patients had acquired morbidity at PICU and hospital discharge, respectively. Median baseline FSS was 6.00 (6.00, 6.25), which increased to 11.00 (8.75, 12.00) at PICU discharge before decreasing to 7.50 (6.00, 9.25) at hospital discharge. All patients had significantly higher median FSS score at both PICU and hospital discharge compared to baseline. Feeding and respiratory were the most affected domains. After adjusting for severity of illness, severity categories of PARDS was not a risk factor for acquired morbidity. Conclusion: Acquired morbidity in respiratory and feeding domains was common in PARDS survivors. Specific attention should be given to these two domains of functional outcomes in these children.

scholarly journals Surfactant Utilization Evaluation in a Major Teaching Hospital in West of Iran: An Observational, Prospective Study

2022 ◽  
Author(s):  
Sajad Khiali ◽  
Mohammadbagher Hosseini ◽  
Elnaz Shaseb
Keyword(s):  
Respiratory Distress Syndrome ◽  
Respiratory Distress ◽  
Replacement Therapy ◽  
Teaching Hospital ◽  
Neonatal Intensive Care ◽  
Distress Syndrome ◽  
Standard Dose ◽  
Surfactant Replacement ◽  
Surfactant Replacement Therapy ◽  
Clinical Records

Background: The respiratory distress syndrome (RDS) is a common pulmonary disorder that usually occurs as a result of preterm labor and is associated with lack of surfactant. The aim of this study was to evaluate the pattern of surfactant prescription in Alzahra teaching hospital in Tabriz, Iran. Methods: This drug use evaluation (DUE) study was conducted in the neonatal intensive care unit (NICU) of Al-Zahra Hospital, Tabriz, Iran. The demographic and clinical data collection was performed using clinical records of patients. The pattern of surfactant replacement therapy was evaluated and compared with the European Consensus Guideline on the management of respiratory distress syndrome in 2016. Results: A total of 252 premature infants who received surfactant between August 2017 and March 2018 were included. 80.8% of neonates were born by cesarean section. The most used surfactant was Curosurf®, which was used in 82.1% of cases. Only 34.9% of the infants received within 8 hours of birth. Moreover, 79% of infants received the standard dose of surfactant, while 9.5 % and 11.5% were given high and low doses of surfactant, respectively. Conclusion: The pattern of surfactant replacement therapy was not completely according to the guidelines, particularly regarding the time of administration.  Considering the importance of dose and timely administration of surfactant, providing strategies to decrease these errors are important. 

Sign in / Sign up

Export Citation Format

Share Document